**Question:** All of the following statements about Esophageal carcinoma are true, Except:

A. Esophageal carcinoma is a rare disease.
B. Esophageal carcinoma is a type of gastrointestinal cancer.
C. Esophageal carcinoma is more common in males than females.
D. Esophageal carcinoma rarely spreads to other parts of the body.

**Core Concept:** Esophageal carcinoma is a type of cancer that starts in the cells of the esophagus, the muscular tube that connects the mouth and stomach. Esophageal cancer can be classified into two main types: squamous cell carcinoma (SCC) and adenocarcinoma (AC).

**Why the Correct Answer is Right:** Option A is incorrect because esophageal carcinoma is not a rare disease. It is the eighth most common cancer worldwide and the ninth leading cause of cancer death. Esophageal cancer has a high mortality rate due to its advanced stage at diagnosis.

**Why Each Wrong Option is Incorrect:**

A. Esophageal carcinoma is a type of gastrointestinal cancer (GI cancer). While it starts in the esophagus, which is part of the GI tract, it is a specific type of cancer and not a general classification of GI cancers.

B. Esophageal carcinoma is a rare disease. This statement is incorrect because it is not rare, as mentioned above.

C. Esophageal carcinoma is more common in males than females. This statement is true, as the risk factors and etiology of esophageal cancer are different for males and females. Males are more affected due to higher alcohol consumption, smoking, and Barrett's esophagus prevalence.

D. Esophageal carcinoma rarely spreads to other parts of the body. This statement is incorrect because esophageal cancer can spread to distant organs through the lymphatic system and bloodstream. When it does, it becomes advanced and has a poorer prognosis.

**Clinical Pearl:** Esophageal cancer is a disease with significant health impacts and requires thorough understanding of its epidemiology, risk factors, and clinical presentation. Early detection, diagnosis, and treatment are essential to improve patient outcomes and survival rates.